PRESENTED BY: Scott Dryden-Peterson, MD, MSc, Infectious Disease, Brigham and Women’s Hospital; Principal Investigator, Botswana Harvard Health Partnership.
VIRTUALLY: Join via Zoom (https://harvard.zoom.us/j/97502795097?pwd=dXNJcEEwbSt4cFFmZGt0UVl1UWxmdz09)
MEETING ID: 975 0279 5097 PASSCODE: 960115
Connect with the speaker via social media: X (https://twitter.com/SDrydenPeterson)
Dr. Dryden-Peterson is an Assistant Professor of Medicine at Harvard Medical School Associate Physician at Mass General Brigham and Dana Farber Cancer Institute and a Research Associate at the Botswana Harvard Partnership an independent research institution in Botswana. He is a specialist infectious diseases clinician at the Dana Farber Cancer Institute and Brigham and Women’s Hospital. Other leadership roles held by Dr. Dryden-Peterson include co-Director of the oncology capacity collaboration BOTSOGO Medical Director of COVID outpatient therapy at Mass General Brigham and co-Director of the HIV and Malignancy Scientific Working Group of Harvard CFAR. His research focuses on cancers arising the context of HIV which have become the leading cause of death for people living with HIV globally. This work is primarily based at the Botswana Harvard Health Partnership in Gaborone where he leads teams examining mechanisms of excess risk of cancer disparities in treatment outcomes among individuals with HIV infection and strategies to improve access to timely oncology care in resource-constrained contexts. Dr. Dryden-Peterson has served as mentor to 35 pre- and postdoctoral researchers in the past 10 years.
If you have questions, please contact Kate Devine at kdevine9@mgh.harvard.edu or visit the HOPE Conference website at http://www.hopeconference.net/ for archived presentations and lecture slides.